Evidence map›Paper›PMID 39665620›Full record

ArticleeLife2024

A multiplexed, single-cell sequencing screen identifies compounds that increase neurogenic reprogramming of murine Muller glia.

Amy Tresenrider, Marcus Hooper, Levi Todd, Faith Kierney, Nicolai A Blasdel, Cole Trapnell, Thomas A Reh

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. The neuroimmune interface in retinal regeneration.Progress in retinal and eye research · 2025
    Review
  6. Article
  7. Article
  8. The Healthy and Diseased Retina Seen through Neuron-Glia Interactions.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Amy TresenriderDepartment of Genome Sciences, University of Washington, Seattle, United States.ORCID https://orcid.org/0000-0002-0819-9187
Marcus HooperDepartment of Biological Structure, University of Washington, Seattle, United States.
Levi ToddDepartment of Biological Structure, University of Washington, Seattle, United States.ORCID https://orcid.org/0000-0003-2561-7675
Faith KierneyDepartment of Biological Structure, University of Washington, Seattle, United States.
Nicolai A BlasdelDepartment of Biological Structure, University of Washington, Seattle, United States.
Cole TrapnellDepartment of Genome Sciences, University of Washington, Seattle, United States.
Thomas A RehDepartment of Biological Structure, University of Washington, Seattle, United States.ORCID https://orcid.org/0000-0002-3524-0886

Funding

Supplement to EY021482 to carry out a screen for retinal regeneration using CRISPR-Cas9 gene activation.R01EY021482 · NEI · UNIVERSITY OF WASHINGTON · PI THOMAS A REH · 2011 to 2026
$6.3M
Versatile, exponentially scalable methods for single cell molecular profilingR01HG010632 · NHGRI · UNIVERSITY OF WASHINGTON · PI Jay Ashok Shendure, Bruce Colston Trapnell · 2019 to 2026
$5.9M
Investigation of the neuroimmune axis in retinal regeneration.K99EY033402 · NEI · UNIVERSITY OF WASHINGTON · PI TODD, LEVI J. · 2022 to 2023
$240k
Expanding retinal regenerative potential through chromatin biology in single cellsF32EY032331 · NEI · UNIVERSITY OF WASHINGTON · PI TRESENRIDER, AMY · 2022 to 2023
$123k
Chan Zuckerberg Initiative CZF2019-002442Foundation Fighting Blindness TA-RM-0620-0788-UWAInternational Retina Research Foundation FellowshipNEI NIH HHS 1F32EY032331NEI NIH HHS F32 EY032331NEI NIH HHS K99 EY033402NEI NIH HHS K99EY033402NEI NIH HHS R01 EY021482NEI NIH HHS R01EY021482-12NHGRI NIH HHS 1R01HG010632NHGRI NIH HHS R01 HG010632Paul G. Allen Family Foundation Allen Discovery Center grant 12357
6 · The paper itself

Abstract

Retinal degeneration in mammals causes permanent loss of vision, due to an inability to regenerate naturally. Some non-mammalian vertebrates show robust regeneration, via Muller glia (MG). We have recently made significant progress in stimulating adult mouse MG to regenerate functional neurons by transgenic expression of the proneural transcription factor Ascl1. While these results showed that MG can serve as an endogenous source of neuronal replacement, the efficacy of this process is limited. With the goal of improving this in mammals, we designed a small molecule screen using sci-Plex, a method to multiplex up to thousands of single-nucleus RNA-seq conditions into a single experiment. We used this technology to screen a library of 92 compounds, identified, and validated two that promote neurogenesis in vivo. Our results demonstrate that high-throughput single-cell molecular profiling can substantially improve the discovery process for molecules and pathways that can stimulate neural regeneration and further demonstrate the potential for this approach to restore vision in patients with retinal disease.

Indexed as

Ependymoglial CellsNeurogenesisSingle-Cell AnalysisAnimalsCellular ReprogrammingMicecell signalinggeneticsgenomicsmouseneuronregenerative medicinereprogrammingretinasingle-cell sequencingstem cells

Identifiers

PMID39665620
PMCPMC11637464

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.